(Q35838382)

English

A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

10 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Frank Kässner

1

1 reference

Europe PubMed Central

10 August 2017

Rick Hodder

2

1 reference

Europe PubMed Central

10 August 2017

Eric D Bateman

3

1 reference

Europe PubMed Central

10 August 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

64

1 reference

Europe PubMed Central

10 August 2017

15

1 reference

Europe PubMed Central

10 August 2017

1671-1682

1 reference

Europe PubMed Central

10 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200464150-00005

0 references

Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute controlled study of the dose-response relationship of fenoterol, ipratropium bromide and their combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National and international guidelines for the diagnosis and treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological effects of a combination of fenoterol hydrobromide and ipratropium bromide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Role of Bronchodual in the long-term treatment of asthma in children]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Berodual and salbutamol in asthma: a multicenter evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration errors with a conventional metered dose inhaler versus a novel breath actuated device

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing the in vitro performance of Respimat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting drugs to the airways by different inhalation devices: role of deposition characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two aerosols containing both fenoterol and ipratropium in a high (Duovent) and low (Berodual) concentration, respectively

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response relationship: fenoterol, ipratropium bromide and their combination.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover s

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted delivery of inhaled drugs: current challenges and future goals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing metered-dose inhaler technique: comparison of observation vs. patient self-report

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Evaluation of the bronchodilatory activity of berodual and its components: fenoterol and ipratropium bromide in children with bronchial asthma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivery of fenoterol via Respimat, a novel 'soft mist' inhaler. a randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat((R)) Soft Misttrade mark Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15257628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200464150-00005

1 reference

Europe PubMed Central

10 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35838382&oldid=1601585612"